Senin, 06 April 2015

UPDATE 1-Ocular's eye drug misses a main goal in second late-stage study

April 6 (Reuters) - Ocular Therapeutix Inc said its lead eye drug failed to meet one of the main goals in a second late-stage study.





from Reuters: Hot Stocks http://ift.tt/1GZOuLh

Tidak ada komentar:

Posting Komentar